Literature DB >> 5480863

A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.

D Seidel, P Alaupovic, R H Furman, W J McConathy.   

Abstract

The plasma low density lipoproteins (LDL) in biliary obstruction are characterized almost exclusively by the presence of the immunochemically distinct lipoprotein families, lipoprotein B (LP-B) and lipoprotein X (LP-X). It is suggested that LP-X, with its uniquely high content of unesterified cholesterol and phospholipid, is primarily responsible for the unusual lipid composition of LDL and the abnormal plasma lipid composition in obstructive jaundice. To show their protein moieties, we isolated LP-X and LP-B from the LDL in plasma obtained from patients with obstructive jaundice. A separation procedure was employed which combines ultracentrifugation, heparin precipitation, and ethanol fractionation. Whereas LP-B was characterized by the presence of apolipoprotein B (ApoB), intact LP-X contained a protein moiety of unique composition consisting of a mixture of albumin (approximately 40%) and the specific apolipoprotein, ApoX (60%). These two protein moieties were separated by preparative ultracentrifugation at d 1.21 g/ml of a solution of partially delipidized LP-X. LP-X thus comprises an albumin-lipoprotein complex in which the masked antigenic site of albumin can be revealed by partial or total delipidization. Apolipoprotein X, the characteristic nonalbumin protein moiety of intact or partially delipidized LP-X, was immunochemically different from ApoA, ApoB, albumin, gamma-globulins, and other serum proteins. The results of analytical ultracentrifugation and the immunochemical and electrophoretic properties of ApoX indicated it to be a complex protein consisting possibly of several nonidentical polypeptides. ApoX was characterized by its amino acid composition, and by serine and threonine as the major N-terminal and alanine as the major C-terminal amino acids. It has been suggested that ApoX is similar to, if not identical with, apolipoprotein C.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5480863      PMCID: PMC322741          DOI: 10.1172/JCI106459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  [Separation by ultracentrifugation of the alpha-lipoproteins of normal human serum].

Authors:  M AYRAULT-JARRIER; G LEVY; R WALD; J POLONOVSKI
Journal:  Bull Soc Chim Biol (Paris)       Date:  1963

3.  Ultracentrifugal characterization of the lipoprotein spectrum in obstructive jaundice: studies of serum lipid relationships in intra-and extrahepatic biliary obstruction.

Authors:  R H FURMAN; L L CONRAD
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

4.  Starch gel electrophoresis in a discontinous system of buffers.

Authors:  M D POULIK
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

5.  Isolation and characterization of human chyle chylomicrons and lipoproteins.

Authors:  P Alaupovic; R H Furman; W H Falor; M L Sullivan; S L Walraven; A C Olson
Journal:  Ann N Y Acad Sci       Date:  1968-11-21       Impact factor: 5.691

6.  Observations on the protein components of human plasma high- and low-density lipoproteins.

Authors:  D Rudman; L A Garcia; L L Abell; S Akgun
Journal:  Biochemistry       Date:  1968-09       Impact factor: 3.162

7.  [Isolation and study of abnormal serum lipoproteins during retention jaundice after flocculation by polyvinylpyrrolidone].

Authors:  M Burstein; J Caroli
Journal:  Rev Fr Etud Clin Biol       Date:  1968-04

8.  Heterogeneity in protein subunits of human serum high-density lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

9.  Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma.

Authors:  D M Lee; P Alaupovic
Journal:  Biochemistry       Date:  1970-05-26       Impact factor: 3.162

10.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

View more
  26 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

3.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

Review 4.  Newer diagnostic procedures in pancreatobiliary surgery.

Authors:  F Nakayama
Journal:  Jpn J Surg       Date:  1972-06

5.  Liquid crystalline lipid in the plasma of humans with biliary obstruction.

Authors:  S H Quarfordt; H Oelschlaeger; W R Krigbaum
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

Review 6.  [Lipid-protein-interactions of human apolipoproteins-structural aspects and models of lipoproteins (author's transl)].

Authors:  G Middelhoff; J Augustin; G Klose; H Greten
Journal:  Klin Wochenschr       Date:  1977-02-15

7.  Formation of lipoprotein-X. Its relationship to bile compounds.

Authors:  E Manzato; R Fellin; G Baggio; S Walch; W Neubeck; D Seidel
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 8.  Plasma lipids and lipoproteins in liver disease.

Authors:  N McIntyre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

9.  Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.

Authors:  G Kajiyama; K Takata; I Horiuchi; M Nakagawa; M Yamamoto; A Miyoshi
Journal:  Gastroenterol Jpn       Date:  1983-04

10.  [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].

Authors:  D Seidel
Journal:  Klin Wochenschr       Date:  1977-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.